We are live on ! Find out more
Citadel Advisors

Citadel Advisors Portfolio holdings

AUM $875B
1-Year Est. Return 40.91%
 

Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.

This Fund
S&P 500
This Quarter Est. Return
-1.7%
1 Year Est. Return
+40.91%
3 Year Est. Return
+115.85%
5 Year Est. Return
+132.1%
10 Year Est. Return
+518.81%
AUM
$439B
AUM Growth
+$49B
Cap. Flow
+$65.7B
Cap. Flow %
14.98%
Top 10 Hldgs %
33.97%
Holding
14,356
New
1,622
Increased
5,458
Reduced
5,222
Closed
1,858

Top Buys

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$703M
2
TSLA icon
Tesla
TSLA
+$585M
3
JPM icon
JPMorgan Chase
JPM
+$582M
4
AMZN icon
Amazon
AMZN
+$566M
5
TLT icon
iShares 20+ Year Treasury Bond ETF
TLT
+$466M

Top Sells

Rank Stock Value
1
META icon
Meta Platforms (Facebook)
META
+$349M
2
HD icon
Home Depot
HD
+$334M
3
TMUS icon
T-Mobile US
TMUS
+$270M
4
CI icon
Cigna
CI
+$258M
5
CDW icon
CDW
CDW
+$237M

Sector Composition

Rank Sector Weight
1 Technology 3.12%
2 Healthcare 2.55%
3 Financials 2.39%
4 Consumer Discretionary 2.14%
5 Industrials 1.62%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ALOY
11951
REalloys Inc
ALOY
$1B
$22K ﹤0.01%
+7,396
New +$34.9K
CARM
11952
PUT
DELISTED
Carisma Therapeutics
CARM
$22K ﹤0.01%
2,535
+60
+2% +$817
CGEN icon
11953
CALL
Compugen
CGEN
$228M
$22K ﹤0.01%
+33,600
New +$47.5K
CTMX icon
11954
CALL
CytomX Therapeutics
CTMX
$732M
$22K ﹤0.01%
15,300
+600
+4% +$923
CHRN
11955
CALL
ChronoScale Holdings
CHRN
$3.04B
$22K ﹤0.01%
953
-1,594
-63% -$47.1K
GORO icon
11956
PUT
Goldgroup Mining Inc.
GORO
$207M
$22K ﹤0.01%
13,600
-13,800
-50% -$23.4K
IKT icon
11957
Inhibikase Therapeutics
IKT
$378M
$22K ﹤0.01%
+4,019
New +$21.1K
KULR icon
11958
PUT
KULR Technology Group
KULR
$122M
$22K ﹤0.01%
2,138
-1,887
-47% -$22.4K
OLOX
11959
CALL
Olenox Industries
OLOX
$3.7M
$22K ﹤0.01%
2
-4
-67% -$46.7K
SLS icon
11960
PUT
SELLAS Life Sciences
SLS
$2.58B
$22K ﹤0.01%
10,700
-100
-0.9% -$276
ZENV
11961
DELISTED
Zenvia
ZENV
$22K ﹤0.01%
+13,845
New +$28.2K
CSLMW
11962
DELISTED
CSLM Acquisition Corp. Warrant
CSLMW
$22K ﹤0.01%
438,300
+800
+0.2% +$57
TTOO
11963
DELISTED
T2 Biosystems, Inc
TTOO
$22K ﹤0.01%
39
-20
-34% -$13.2K
AFIB
11964
CALL
DELISTED
Acutus Medical Inc
AFIB
$22K ﹤0.01%
25,400
+1,100
+5% +$1.33K
FGH
11965
CALL
DELISTED
FG Group Holdings Inc.
FGH
$22K ﹤0.01%
10,800
-16,300
-60% -$40K
LTCH
11966
DELISTED
Latch, Inc. Common Stock
LTCH
$22K ﹤0.01%
23,392
-1,131,764
-98% -$1.3M
WTT
11967
DELISTED
Wireless Telecom Group, Inc.
WTT
$22K ﹤0.01%
+16,672
New +$23.2K
CYAD
11968
DELISTED
Celyad Oncology SA American Depositary Shares
CYAD
$22K ﹤0.01%
+16,654
New +$30.6K
LHDX
11969
CALL
DELISTED
Lucira Health, Inc. Common Stock
LHDX
$22K ﹤0.01%
21,200
+9,900
+88% +$22.6K
KAL
11970
DELISTED
Kalera Public Limited Company Ordinary Shares
KAL
$22K ﹤0.01%
164
+31
+23% +$8.37K
AHG
11971
Akso Health Group
AHG
$1.09B
$21K ﹤0.01%
+23,209
New +$24.6K
APLT
11972
CALL
DELISTED
Applied Therapeutics
APLT
$21K ﹤0.01%
+22,200
New +$26.6K
AQST icon
11973
Aquestive Therapeutics
AQST
$533M
$21K ﹤0.01%
18,063
-53,932
-75% -$61K
ATOS icon
11974
Atossa Therapeutics
ATOS
$25.9M
$21K ﹤0.01%
1,728
-14,524
-89% -$211K
BARK icon
11975
BARK
BARK
$91.4M
$21K ﹤0.01%
574
-70,662
-99% -$2.61M

Similar funds

Citadel Advisors's Q3 2022 Portfolio in Review

As of Q3 2022, Citadel Advisors held 14,356 positions worth $439B, up 13% from $390B the previous quarter. Its ten largest holdings account for 34% of the portfolio.

Citadel Advisors deployed $65.7B of net new capital in Q3 2022, opening 1,622 new positions and adding to 5,458 existing holdings. Its largest new stake was SentinelOne: 4,426,634 shares worth $113M.

By sector, the portfolio is most concentrated in Technology at 3.1% of assets, up from 2.8% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was Meta Platforms (Facebook), an estimated $349M trimmed.

  • Citadel Advisors's largest Q3 2022 buy was SentinelOne: 4,426,634 shares worth $113M.
  • Citadel Advisors added most to Apple in Q3 2022, an estimated $703M increase.
  • Citadel Advisors's biggest Q3 2022 reduction was Meta Platforms (Facebook), cutting an estimated $349M.
  • Citadel Advisors fully exited Regions Financial in Q3 2022, selling an estimated $207M.
  • Citadel Advisors's ten largest holdings make up 34% of its $439B portfolio in Q3 2022.
  • Citadel Advisors opened 1,622 new positions and closed 1,858 in Q3 2022.
  • Citadel Advisors's portfolio value rose 13% quarter-over-quarter to $439B.

Based on Citadel Advisors's 13F filing for Q3 2022, filed 14 Nov 2022.